Related content

Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis

By Yokota Shumpei   Miyamae Takako   Imagawa Tomoyuki   Iwata Naomi   Katakura Shigeki   Mori Masaaki  

Modern Rheumatology, Vol. 14, Iss. 1, 2004-03 ,pp. : 12-17

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-1 as a therapeutic target in systemic-onset juvenile idiopathic arthritis

By Allantaz Florence   Stichweh Dorothee   Pascual Virginia  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 305-312

Future Medicine

Access to resources Recommend Favorite

TNF‐&agr; promoter gene polymorphisms in Spanish children with persistent oligoarticular and systemic‐onset juvenile idiopathic arthritis

By Modesto C.   Patiño A.   Sotillo E.   Merino J.   García J.   Merino R.   Rua M. J.   Sierrasesúmaga L.   Arnal C.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 6, 2005-11 ,pp. : 451-454

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis

By Jelušić Marija   Lukić Ivan   Tambić-Bukovac Lana   Dubravčić Klara   Malčić Ivan   Rudan Igor   Batinić Drago  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1332-1334

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis

By Alexeeva Ekaterina   Valieva Saniya   Bzarova Tatyana   Semikina Elena   Isaeva Kseniya   Lisitsyn Alexander   Denisova Rina   Chistyakova Evgeniya  

Clinical Rheumatology, Vol. 30, Iss. 9, 2011-09 ,pp. : 1163-1172

Springer Publishing Company

Access to resources Recommend Favorite